bioRxivCell Biology
Studying the fate of tumor extracellular vesicles at high spatio-temporal resolution using the zebrafish embryo
V. Hyenne, S. Ghoroghi, M. Collot, S. Harlepp, J. Bauer, L. Mercier, I. Busnelli, O. Lefebvre, N. Fekonja, P. Machado, J. Bons, F. Delalande, A. I. Amor, S. G. Silva, F. J. Verweij, G. Van Niel, Y. Schwab, H. Peinado, C. Carapito, A. S. Klymchenko, J. G. Goetz
Abstract
Tumor extracellular vesicles (tumor EVs) mediate the communication between tumor and stromal cells mostly to the benefit of tumor progression. Notably, tumor EVs have been reported to travel in the blood circulation, reach specific distant organs and locally modify the microenvironment. However, visualizing these events in vivo still faces major hurdles. Here, we show a new method for tracking individual circulating tumor EVs in a living organism: we combine novel, bright and specific fluorescent membrane probes, MemBright, with the transparent zebrafish embryo as an animal model. We provide the first description of tumor EVs hemodynamic behavior and document their arrest before internalization. Using transgenic lines, we show that circulating tumor EVs are uptaken by endothelial cells and blood patrolling macrophages, but not by leukocytes, and subsequently stored in acidic degradative compartments. Finally, we prove that the MemBright can be used to follow naturally released tumor EVs in vivo. Overall, our study demonstrates the usefulness and prospects of zebrafish embryo to track tumor EVs in vivo.\n\nHighlightsO_LIMemBright, a new family of membrane probes, allows for bright and specific staining of EVs\nC_LIO_LIZebrafish melanoma EVs are very similar to human and mouse melanoma EVs in morphology and protein content\nC_LIO_LIThe zebrafish embryo is an adapted model to precisely track tumor EVs dynamics and fate in a living organism from light to electron microscopy\nC_LIO_LICirculating tumor EVs are rapidly uptaken by endothelial cells and patrolling macrophages\nC_LIO_LICorrelated light and electron microscopy can be used in zebrafish to identify cells and compartments uptaking tumor EVs\nC_LI\n\nBlurbDispersion of tumor extracellular vesicles (EVs) throughout the body promotes tumor progression. However the behavior of tumor EVs in body fluids remains mysterious due to their small size and the absence of adapted animal model. Here we show that the zebrafish embryo can be used to track circulating tumor EVs in vivo and provide the first high-resolution description of their dissemination and uptake.
- organism: zebrafish
- assay: imaging
- assay: fluorescence / live-cell microscopy
- research focus: cell type annotation
- research focus: cell-cell communication
- research focus: spatial domain detection
- approach: experimental assay
- approach: microscopy & imaging analysis
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Blood flow diverts extracellular vesicles from endothelial degradative compartments to promote angiogenesis
- Live tracking of inter-organ communication by endogenous exosomes in vivo
F. J. Verweij, C. Revenu, … G. van Niel·bioRxiv·Jul 30, 2018
- In vivo characterisation of endogenous cardiovascular extracellular vesicles in larval and adult zebrafish
A. Scott, L. Sueiro Ballesteros, … R. J. Richardson·bioRxiv·Jun 12, 2020
- Fluid shear stress modulates endocytic pathways and junctional targeting of tumor-derived extracellular vesicles in endothelial cells
Nícolas Jones Villarinho, Bong Hwan Sung, … Vanessa M. Freitas·bioRxiv·May 5, 2026
- Membrane Protein Modification Modulates Big and Small Extracellular Vesicle Biodistribution and Tumorigenic Potential in Breast Cancers In Vivo
B. J. A. Magoling, A. Y.-T. Wu, … C. P. Lai·bioRxiv·Sep 28, 2022
- In vitro and in vivo analysis of microvesicle-mediated metastasis using a bright, red-shifted bioluminescent reporter protein of extracellular vesicles
A. A. Zarea, G. I. Perez, … M. Kanada·bioRxiv·Jul 23, 2021